Novel biguanide-based derivatives scouted as TAAR1 agonists: Synthesis, biological evaluation, ADME prediction and molecular docking studies

Michele Tonelli, Stefano Espinoza, Raul R. Gainetdinov, Elena Cichero

Research output: Contribution to journalArticlepeer-review

Abstract

Trace amines (TAs) are endogenous neuromodulators that play a functional role in the synaptic transmission within central nervous system (CNS), targeting trace amine-associated receptors (TAARs). Starting from our previous computational studies on TAAR1 and TAAR5 interactions with the unselective ligand 3-iodothyronamine (T1AM), we investigated the functional activity at murine and human TAAR1 and murine TAAR5 receptors of twenty-seven biguanide-based derivatives, including six newly synthesized compounds. Phenyl (BIG2, BIG4, BIG8 and BIG22) or benzyl (BIG10-BIG16) biguanides were found to be selective murine and human TAAR1 agonists with potencies in nanomolar or low micromolar range, respectively. In particular, compounds BIG2 and BIG12-BIG14 were the most promising and they could be considered valuable lead compounds worthy of further investigations. In addition to the interest for developing more effective human TAAR1 ligands, the disclosed here potent murine TAAR1 agonists could offer suitable tools for studying the pharmacology of TAAR1 receptor.

Original languageEnglish
Pages (from-to)781-792
Number of pages12
JournalEuropean Journal of Medicinal Chemistry
Volume127
DOIs
Publication statusPublished - 2017
Externally publishedYes

Keywords

  • Benzyl biguanide derivatives
  • Murine and human TAAR1 agonists
  • Phenyl biguanide derivatives
  • Trace amine-associated receptors (TAARs)

Fingerprint

Dive into the research topics of 'Novel biguanide-based derivatives scouted as TAAR1 agonists: Synthesis, biological evaluation, ADME prediction and molecular docking studies'. Together they form a unique fingerprint.

Cite this